The form was uploaded to medical-data-models.org - Original URL: https://medical-data-models.org/15532
StudyName: Month 15: Vital Signs Multiple Sclerosis ALAIN01 NCT02419378
Date of export from the portal: 02.07.2020
Date of Upload / last change: 02.06.2016
License: Creative Commons BY 4.0

----

Description: 
Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential (ALAIN01)
https://clinicaltrials.gov/ct2/show/NCT02419378
Principal Investigator Prof. Dr. Dr. Sven Meuth, University Hospital Muenster, Germany

Please document clinically significant findings as Adverse Events. Clinical Significance is
defined as any variation in physical findings that has medical relevance and may result in an
alteration in medical care.

Safety Blood and Urine Examinations: Please document the results for Serum Creatinine, Platelets and TSH on CRF-Pages "Safety
Laboratory Assessments".

Part: Month 15
